Close menu




January 29th, 2026 | 07:00 CET

Puma takeover is becoming more concrete! Should investors buy Evotec and Silver Viper shares next?

  • Mining
  • Silver
  • Commodities
  • Biotechnology
  • Sportswear
  • Takeover
Photo credits: Puma SE

Takeover speculation has been swirling around Puma for some time. Now it has become more tangible: Anta has secured a 29% stake in the German sporting goods group, paying EUR 35 per share. However, the euphoria on the stock market is limited. Are there better opportunities for investors to profit from takeover speculation? One candidate in the hot silver market is Silver Viper. The Company is pushing ahead with exciting projects in Mexico. Its recent capital increase met with strong demand, and a financially powerful potential buyer already has a foot in the door. And what about Evotec? The perennial takeover candidate is still not gaining momentum. That said, the biotech company is benefiting from the sale of one of its own holdings, which is expected to bring in around USD 160 million.

time to read: 5 minutes | Author: Fabian Lorenz
ISIN: PUMA SE | DE0006969603 , EVOTEC SE INH O.N. | DE0005664809 , SILVER VIPER MINER. CORP. | CA8283344098

Table of contents:


    Silver Viper: Buyer already has a foot in the door

    The price of silver is simply unstoppable. An ounce now costs around USD 115. At the beginning of 2026, it was just over USD 70. Even if there is a pause for breath, the overall trends remain positive. Silver is not only a precious metal, but also a critical metal. Without silver, electromobility, photovoltaics, and other areas face major problems. The fact that supply is structurally limited has long been ignored by investors. This makes explorers with exciting projects all the more interesting. One of these is Silver Viper Minerals.

    The experts at researchanalyst.com have taken a closer look at the Company and come to a clear conclusion: Silver Viper Minerals is more than a classic exploration bet. The combination of high-quality projects, industrial validation by Fresnillo, and experienced management is exceptional. With a market capitalization of less than CAD 180 million, the Company offers investors considerable upside potential if exploration is successful and the precious metals market remains strong.

    Silver Viper's three core projects are all located in productive and historically proven precious metal regions of Mexico. Operational efficiency, regulatory experience, and access to existing infrastructure are made possible by the regional focus. Geologically, Silver Viper primarily targets epithermal gold-silver systems and polymetallic structures. These are responsible for numerous Tier 1 deposits in Mexico. And Mexico dominates the global silver market with around 6,300 tons of annual production. Approximately 52,000 meters of drilling have already been completed at the flagship La Virginia project, which has created a solid basis for targeted follow-up programs.

    The latest capital measure showed that investors are convinced of Silver Viper's prospects. Approximately CAD 17 million was raised within a short period of time. This will allow the Company to continue to push ahead with exploration. Incidentally, the anchor shareholder is Fresnillo, the world's largest silver producer. This means that a potential buyer already has a foot in the door. Management also has a significant stake of around 15% and is likely to have a strong interest in seeing the share price rise.

    Note: For those who would like to learn more about the exciting developments at Silver Viper firsthand, register for the International Investment Forum ii-forum.com on February 25, 2026. CEO Stephen Cope will be presenting live.

    Puma: Anta gets involved, but...

    After months of speculation, here are the facts. Anta Sports Products Limited is acquiring a 29.06% stake in Puma, subject to the relevant regulatory approvals and the usual closing conditions. The Chinese Anta Group owns various sports brands such as Fila and Jack Wolfskin and is active worldwide. The seller of the Puma shares is Groupe Artémis, the investment company of the billionaire Pinault family. The value of the stake amounts to EUR 1.5 billion. The Chinese group is willing to pay EUR 35 per Puma share. While Puma has not yet commented on the transaction, Anta has published a detailed press release.

    Anta Sports sees the investment as a way to accelerate globalization. The aim is to usher in the next chapter of growth for global sports markets, including China, and to create lasting value for consumers and shareholders of both companies worldwide. Anta is looking forward to working with Puma to realize the full potential of the brand.

    Anta Chairman Ding Shizhong explained the strategic reasons for the transaction: "Anta has always admired Puma's long-term brand value and potential. Such strong brand DNA and a tradition of values like this are rare to find. We believe that Puma's share price in recent months does not fully reflect the brand's long-term potential. We have confidence in the management team and the strategic transformation. Looking ahead, we hope to build a strong relationship of trust, work together as equals, and leverage our complementary strengths without compromising independence. We look forward to supporting the brand's ongoing revitalization."

    Anta Sports is seeking appropriate representation on Puma's supervisory board. Opportunities to further deepen the partnership are being explored, but there are currently no plans for a takeover bid. This is likely also the reason why Puma shares opened at EUR 26 on Tuesday but quickly fell to EUR 22. The stock closed at EUR 23.58, well below the price paid by Anta.

    Register for free to participate in the upcoming International Investment Forum on February 25

    Evotec: The eternal takeover candidate

    When it comes to takeover candidates, the name Evotec always comes up. But since the dubious offer at the end of 2024, things have quietened down around the biotech company. Yet Evotec's platform is repeatedly described as attractive for potential buyers. The data and screening ecosystem is considered challenging to replicate and can be easily integrated into AI-supported research.

    Evotec is also active in the field of AI itself, as shown by the latest announcement. According to this, the subsidiary Just – Evotec Biologics is receiving funding for the AI-supported optimization of the development potential of monoclonal antibodies to improve affordable access. The funding comes from the Gates Foundation. Evotec plans to improve the developability of monoclonal antibodies and reduce costs. The goal is to prevent infectious diseases in low- and middle-income countries. The new funding will enable ten new J.MD™ projects over the next three years to develop biotherapeutics for various globally relevant health indications.

    Even without takeover speculation, RBC at least sees upside potential for Evotec's share price. Analysts have confirmed their "Outperform" recommendation and see the fair value at EUR 10. The stock is currently trading just above EUR 6. In the short term, Evotec is benefiting from Amgen's acquisition of Dark Blue Therapeutics for USD 840 million.
    In this context, Evotec could receive around USD 160 million for its stake in Dark Blue. In the medium term, of course, the development of the research pipeline will determine the share price performance.


    Silver Viper is more than just a takeover story. With this stock, investors could benefit disproportionately from the silver boom. The fact that Anta did not make a takeover bid to all Puma shareholders may have caught some investors off guard. However, the stock does not appear to be expensive. Evotec is always good for a surprise. However, there is no compelling reason to buy the stock at this time.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Carsten Mainitz on January 29th, 2026 | 07:45 CET

    Antimony: Critical raw material becomes a geopolitical factor – Antimony Resources poised for revaluation

    • Mining
    • antimony
    • Defense
    • flameretardant
    • CriticalMetals

    Antimony Resources is quietly emerging as a raw materials story with enormous strategic impact. The critical raw material antimony is relevant to security, indispensable to industry, and too unevenly distributed globally. In an environment where supply chains are politicized and critical raw materials are becoming geopolitical weapons, the Company is set to increasingly come into focus with Bald Hill, the largest antimony project in North America. Investors who recognize the trend early on are securing a place at the beginning of a highly exciting and lucrative investment story.

    Read

    Commented by André Will-Laudien on January 29th, 2026 | 07:30 CET

    The witch dance continues! Another 100% with TKMS, DroneShield, Pasinex, or the new CSG?

    • Mining
    • zinc
    • Defense
    • Drones
    • Commodities

    The stock markets are extremely volatile, so it is time to take a closer look at some of the key players. Many investors are now focusing on a scenario of ongoing war. Hardly anyone expects real peace to be achieved, as a recent survey shows: 72% of those surveyed do not expect any of the existing trouble spots to enter a state of peace in 2026. This means that public skepticism is higher than the current "super summit talks" between the superpowers around the globe would suggest. In addition to defense stocks, commodity stocks also remain in a state of constant battle. Scarce metals appear to be becoming even scarcer, judging by the spot price. Anyone looking at the precarious situation in Europe should take a closer look at Pasinex Resources' zinc project. Here are a few tips on how to generate a 100% return.

    Read

    Commented by Armin Schulz on January 29th, 2026 | 06:55 CET

    Raw materials, armaments, returns: The investment logic behind Almonty Industries, Rheinmetall, and Lockheed Martin

    • Mining
    • Tungsten
    • Defense
    • armaments
    • hightech

    The global economy is under intense pressure. Geopolitical conflicts are causing shortages of critical raw materials and forcing nations to embark on a massive arms race. These two megatrends are creating unique profit opportunities for companies that are positioned at the crucial points of this value chain. Those who understand the strategic connection between vital resources, modern defense technology, and the highest level of security technology can profit. An analysis of the key players - Almonty Industries, Rheinmetall, and Lockheed Martin - reveals how investors can position themselves along this strategic value chain.

    Read